This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Predictably Human, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Aron Cohen - Innovator in Drug Delivery Systems
Introduction
Aron Cohen is a notable inventor based in Jersey City, NJ (US). He has made significant contributions to the field of drug delivery systems, particularly focusing on electronic methods for treatment programs. His innovative approach aims to enhance the effectiveness of drug delivery through advanced technology.
Latest Patents
Cohen holds a patent for a drug delivery system that includes devices and methods designed for use in treatment programs, such as smoking cessation. The system features a mobile platform and a hand-held inhalation delivery device equipped with a controller circuit, power source, sensors, aerosolizer drivers, and a rescue button. This delivery system generates an aerosol mixture from substances in a pod, tailored to the user's treatment program. The controller circuit dynamically controls the aerosolizer drivers to create individually customized aerosol mixtures, allowing for various percentages of substances and different droplet sizes throughout the treatment process.
Career Highlights
Aron Cohen is currently associated with Predictably Human, Inc., where he continues to develop innovative solutions in drug delivery. His work is characterized by a commitment to improving patient outcomes through technology-driven methods.
Collaborations
Cohen collaborates with talented individuals such as Douglas Philip Dean and Liad Yamin, contributing to a dynamic team focused on advancing drug delivery technologies.
Conclusion
Aron Cohen's work in drug delivery systems exemplifies the intersection of technology and healthcare. His innovative patent and ongoing contributions to Predictably Human, Inc. highlight his dedication to improving treatment methods for users.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile